In the Media

Reimagining Medicine? Novartis Wraps Pharma’s First Big Global Pot Deal
In a watershed moment for medical cannabis advocates in the United States, Swiss giant Novartis’ $NVS Sandoz AG unit has tied up with Canadian medical...
Source: Endpoints News
The Promise of Cannabinoids to Treat Pain
The focus of treating pain over the last decade has led to the emergence of a number of opioid drugs. Since their introduction, this method...
Source: Money Inc
Looking Through the Telescope Onto the Horizon: InMed Pharmaceuticals
Nearly every week, there is another cannabis-themed headline such as “New Study Says 97% of Elderly Patients Say Cannabis Makes Them Feel Better, Decrease Prescription...
Source: Terpenes and Testing Magazine
BTV Interview with InMed CEO, Eric Adams Full Version
Source: BTV
Prescription Based Pharmaceutical Products From Cannabis: InMed Turns Ingredients From Cannabis Plants Into Prescription Based Pharmaceutical Products
InMed turns ingredients from cannabis plants into prescription based pharmaceutical products. InMed is a biopharmaceutical company that specializes in the discovery and development of novel,...
Source: BTV